Ignite Creation Date:
2024-10-25 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06512545
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Modified Second Haplo-transplantation for Graft Failure
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Second Haploidentical Transplantation With Modified Regimen for Graft Failure After the First Allogeneic Stem Cell Transplantation
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Graft failure is a fatal complication following allogeneic stem cell transplantation where a second transplantation is usually required for salvage We previously reported encouraging results with a novel FluCy regimen However there are still around 20 patients developed delayed platelet recovery We designed a modified regimen to further improve the hematopoietic reconstitution after second transplantation This prospective single-arm study aims to investigate the safety and efficacy of this modified regimen
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None